BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19296102)

  • 1. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
    Liu Z; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
    Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.
    Shi J; Kim YS; Zhai S; Liu Z; Chen X; Liu S
    Bioconjug Chem; 2009 Apr; 20(4):750-9. PubMed ID: 19320477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.
    Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X
    Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
    Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
    Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
    Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
    Li ZB; Chen K; Chen X
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
    Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
    J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
    Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.
    Dijkgraaf I; Terry SY; McBride WJ; Goldenberg DM; Laverman P; Franssen GM; Oyen WJ; Boerman OC
    Contrast Media Mol Imaging; 2013; 8(3):238-45. PubMed ID: 23606427
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.